The EU's drug regulator will decide on Monday whether to authorise the Pfizer-BioNTech coronavirus vaccine, with desperate countries hoping for the green light to finally start inoculating their citizens.
The Amsterdam-based European Medicines Agency dramatically moved the decision on the jab ahead from December 29, following pressure to accelerate the process from Germany and other EU states.
The clamour for action grew as Britain and the United States have already started giving their citizens the vaccine developed by US giant Pfizer and German firm BioNTech under emergency national rules.
The EU will start Covid-19 inoculations on December 27 providing the EMA grants a one-year conditional marketing authorisation, the European Commission has said.
The regulator said it had worked around the clock to speed things up, but needed to make sure the Pfizer-BioNTech vaccine was safe and effective, in order to avoid any doubts that could affect uptake.
"We have been able to revise the timetables for the evaluation of the Covid-19 vaccines due to the incredible efforts of everybody involved in these assessments," EMA chief Emer Cooke said last week.
"The number of infections is increasing across Europe and we are aware of the huge responsibility we have to get a vaccine to the market as quickly as is feasible, whilst maintaining the robustness of our scientific review."
The EMA said that if a decision is not possible at the meeting on Monday, then it will hold another meeting on the original December 29 date to rethink.
A decision on another vaccine produced by US firm Moderna is due by January 6.
- German pressure -
The Pfizer-BioNTech vaccine has proven to be 95 percent effective in global trials where two doses are injected three weeks apart.
It must be stored at -70 degrees Celsius (-94 degrees Fahrenheit), a temperature much lower than standard freezers and which forced the company to develop special containers for transport.
The EMA has been carrying out a so-called "rolling review" on the vaccine involving lab tests and large-scale human trials over the past few months, speeding up a process that normally lasts years.
The regulator can grant medicines a conditional marketing authorisation for the EU in public health emergencies. It then follows up with further tests to make sure there are no probl
https://unworldoceansday.org/user/8539
https://unworldoceansday.org/user/8548
https://unworldoceansday.org/user/8557
https://unworldoceansday.org/user/8566
https://unworldoceansday.org/user/8574
https://unworldoceansday.org/user/8825
https://acarey.instructure.com/eportfolios/6463/Home/FILMVF_wonder_woman_1984_Streaming_VF_2020_vostfr_en_Film_Complet
https://acarey.instructure.com/eportfolios/6468/Home/FILMVF_Les_Croods_2__Une_nouvelle_re_Streaming_VF_2020_vostfr_en_Film_Complet
https://acarey.instructure.com/eportfolios/6472/Home/FILMVF_After__Chapitre_2_Streaming_VF_2020_vostfr_en_Film_Complet
https://foriwo3307.medium.com/us-congress-reaches-deal-on-900-bn-covid-19-stimulus-package-ff8cfed50dfd
https://www.mychemicalromance.com/news/us-congress-reaches-deal-900-bn-covid-19-stimulus-package-3626106
https://www.atoallinks.com/2020/us-congress-reaches-deal-on-900-bn-covid-19-stimulus-package-2/
Cambodia's giant life-giving Tonle Sap lake in peril
https://www.mychemicalromance.com/news/cambodias-giant-life-giving-tonle-sap-lake-peril-3626111
https://www.atoallinks.com/2020/cambodias-giant-life-giving-tonle-sap-lake-in-peril-2/
https://www.hybrid-analysis.com/sample/ee94068fa4d73c64be7ab47f687e4238d3fe239cb4246c56f29fe7f3a90c9cf7
https://www.hybrid-analysis.com/sample/eafc05eba7284fee3f31b33860f8be10aa368cb3654c72c157366e240d28148c
https://www.hybrid-analysis.com/sample/a7b19cce750275feba54ea4f2000df622d476ce77bf53b03f72b35ef69891b67
https://www.hybrid-analysis.com/sample/2197457484581fec55e50254a0f7e067ab354cd94d7b67df5e3e0d388ed5976e
https://www.hybrid-analysis.com/sample/e7623edee6fcad51ce0f960cb76e4a6f3f15047398828706e613979164cc6652
https://www.hybrid-analysis.com/sample/57238cab5afdfe294a05bfb6bfa51d241b233c69b4aa97a920c10c8c6e2c4904
https://www.hybrid-analysis.com/sample/da1152833c422f6ad5dd6e86e5247682714f226ce690374d4733422423e0b314
https://paiza.io/projects/zwu1dNR51zEXCoq8kdEGoQ?language=php
https://pastelink.net/2eofh
https://note.com/kaimiaja/n/nbf67ebea297c
https://paste.ofcode.org/pbKVzEchAsdYgfM6CfTTbp
https://controlc.com/56e6e0a9
https://paste.laravel.io/5d34636f-b15e-45e7-a3d3-e4512064d830
https://0paste.com/118704
https://paste.ee/p/P4fSi
https://pasteio.com/xomgzAwKpiq5
https://ideone.com/00mU5R
https://blog.goo.ne.jp/admin/entry/complete?eid=88bae4918c4ef4b76e8ffa8f1c04ee7b&edit=new&sc=
https://www.peeranswer.com/question/5fe05bb9c1a6a47e0443f752
https://www.wsearch1.com/link/92610/watchfull
https://jsfiddle.net/z2cyf841/
http://recampus.ning.com/profiles/blogs/watchfsdfdfgrvsdzfdef
https://caribbeanfever.com/photo/swefewfrreare?context=user
http://zacriley.ning.com/photo/5432375-jpg-r-1920-1080-f-jpg-q-x-xxyxx?context=user
http://network-marketing.ning.com/profiles/blogs/sdfdrfgdzegfergf-1
https://webhitlist.com/forum/topics/watchfull-5